Title of the publicationEffect of formulary policy decisions on antimicrobial drug utilization in British Columbia
Abstract

Background: Formularies are used routinely for management of drug expenditures yet evaluations of their impact remain rare. The objective of this study was to analyse the impact of addition or deletion of antimicrobials from the provincial formulary on drug utilization.
Methods: We obtained data from the British Columbia PharmaNet database on all outpatient oral anti- microbial prescriptions from 1996 to 2000 and converted them to their defined daily dose (DDD) equiva- lents according to the ATC system. Trends in utilization associated with a changing formulary status of new antimicrobial agents were analysed. Maximum likelihood estimation was used to determine the rate of increase in utilization resulting from addition to the formulary. Models were adjusted for seaso- nal and temporal trends as well as serial correlation.
Results: During this time period, clarithromycin was on formulary, later delisted, and then relisted again. Valaciclovir and famciclovir were also added to the formulary. During the time clarithromycin was off the formulary, the rate of change in its monthly consumption was 0.0061 DDD/1000 population/ day; following its relisting, the rate of change increased by 818% to 0.0560 DDD/1000 population/day (P 5 0.002). After the listing of valaciclovir on the formulary, the rate of change in its monthly con- sumption increased 57% from a baseline of 0.0014 to 0.0022 DDD/1000 population/day (P 5 0.07). A similar effect was seen with the addition of famciclovir to the formulary whereby the rate of change in monthly consumption increased from 0.0008 (before addition to the formulary) to 0.0018 (after addition to the formulary) (P <_ 0.001).
Conclusions: Listing of antimicrobials on provincial or countrywide formularies is followed temporally with increased utilization. However, before governmental agencies can institute reference-based pri- cing or co-payment programmes, the effect of such a programme on the emergence of antimicrobial resistance and on patient outcomes needs further study.

DOIhttps://doi.org/10.1093/jac/dkh501
Name of the first authorMarra, Fawziah
Year of publication2004
Study design of the publicationTime-series analysis
Method for data collection and analysis
  • Quantitative data - Quantitative data were used during the intervention
Quantitative data - Quantitative data were used during the intervention
Sector
  • Human - All activities regarding organisations and individuals involved in health products and services
Sub-sectorSub-sectors are further units of demarcation within a sector E.g. awareness campaign from veterinarians to cat owners about toxoplasmosis drug resistance and transmission of resistant bacteria: ANIMAL, PETS
Subsector (human)
  • Healthcare delivery
Healthcare delivery